Antiretroviral drugs and the central nervous system

被引:162
|
作者
Enting, RH
Hoetelmans, RMW
Lange, JMA
Burger, DM
Beijnen, JH
Portegies, P
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Neurol H2 214, NL-1105 AZ Amsterdam, Netherlands
[2] Slotervaart Hosp, Dept Pharm, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Natl AIDS Therapy Evaluat Ctr, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Nijmegen Hosp, Dept Clin Pharm, NL-6500 HB Nijmegen, Netherlands
关键词
cerebrospinal fluid; brain; anti-HIV agents; HIV-1; blood-brain barrier;
D O I
10.1097/00002030-199815000-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1941 / 1955
页数:15
相关论文
共 50 条
  • [21] Discontinued drugs in 2006: central and peripheral nervous system drugs
    Collins, Susanne D.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (11) : 1743 - 1751
  • [22] Discontinued drugs 2007: central and peripheral nervous system drugs
    Ebert, Bjarke
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (02) : 109 - 123
  • [24] Central nervous system birth defects and antiretroviral use in pregnancy
    Beckerman, K. P.
    Covington, D.
    Clax, P.
    Martinez-Tristani, M.
    Seekins, D.
    Scheuerle, A.
    Watts, D. H.
    Tilson, H.
    PROCEEDINGS OF THE 8TH WORLD CONGRESS OF PERINATAL MEDICINE, 2007, : 327 - 331
  • [25] The glymphatic system: implications for drugs for central nervous system diseases
    Terhi J. Lohela
    Tuomas O. Lilius
    Maiken Nedergaard
    Nature Reviews Drug Discovery, 2022, 21 : 763 - 779
  • [26] Nanodelivery of antiretroviral drugs to nervous tissues
    Lawal, Sodiq Kolawole
    Olojede, Samuel Oluwaseun
    Faborode, Oluwaseun Samuel
    Aladeyelu, Okikioluwa Stephen
    Matshipi, Matome Nadab
    Sulaiman, Sheu Oluwadare
    Naidu, Edwin Coleridge Stephen
    Rennie, Carmen Olivia
    Azu, Onyemaechi Okpara
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [27] The glymphatic system: implications for drugs for central nervous system diseases
    Lohela, Terhi J.
    Lilius, Tuomas O.
    Nedergaard, Maiken
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (10) : 763 - 779
  • [28] Medicaid spending and utilization for central nervous system drugs
    Baugh, DK
    Pine, PL
    Blackwell, S
    Ciborowski, G
    HEALTH CARE FINANCING REVIEW, 2004, 26 (01): : 57 - 73
  • [29] NEUROLOGICALLY ACTIVE DRUGS IN LIMULUS CENTRAL NERVOUS SYSTEM
    VONBURG, R
    CORNING, WC
    AMERICAN ZOOLOGIST, 1968, 8 (04): : 815 - &
  • [30] CENTRAL NERVOUS-SYSTEM PHARMACOLOGY OF ANTILEUKEMIC DRUGS
    BALIS, FM
    POPLACK, DG
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1989, 11 (01): : 74 - 86